Eli Lilly and Company announced promising results for its next-generation weight-loss drug Thursday, with patients losing up ...

Middle-class Indians trying to lose weight are embracing drugs such as Mounjaro, which is also used to treat diabetes in a ...

The deal involves Eli Lilly, which makes Zepbound and Mounjaro, and Novo Nordisk, the maker of Ozempic and Wegovy. The drugs, ...

President Trump's plan drops the price of Ozempic and Wegovy for Americans, with plans for Medicare to cover the popular ...

Danish drugmaker Novo Nordisk on Tuesday cut the price of its blockbuster weight-loss drug, Wegovy, by up to 33% in India, ...

Novo Nordisk has reduced the prices of Wegovy by 37%. The obesity pen's lowest dose of 0.25 mg will sell at Rs 10,850 for a ...

Lower prices for 15 drugs, including Ozempic and Wegovy, are expected to be announced by the end of the month. The price ...

The announcement comes as the Danish drugmaker struggles to grab significant market share in the Indian market before it ...

Wegovy’s price cut follows Mounjaro’s success in IndiaIndia key market for Novo Nordisk and Eli Lilly’s obesity drugsWegovy’s ...

Danish drugmaker Novo Nordisk on Tuesday announced slashing prices of its weight-loss drug Wegovy by up to 37 per cent in a ...

Wegovy entered India in June and is playing catch-up to Eli Lilly's Mounjaro, whose sales have doubled within months of its launch in March.| News ...

Novo Nordisk cuts Wegovy prices in India by up to 33% to boost access and counter Mounjaro’s growing market lead.